Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.49 |
| ▸ | MGLL | Q99685 | 2/20 | 0.49 |
| ▸ | TLR2 | O60603 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.46 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.45 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.45 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21257004 | 0.87 | ALDH1A1 (0.55) | FAAHMGLLTLR2LMNAMAPT | |
| SCHEMBL29053791 | 0.87 | ALDH1A1 (0.55) | FAAHMGLLTLR2LMNAMAPT | |
| SCHEMBL29577585 | 0.84 | LMNA (0.65) | LMNAMAPTALDH1A1 | |
| SCHEMBL28676563 | 0.84 | LMNA (0.65) | LMNAMAPTALDH1A1 | |
| SCHEMBL28729980 | 0.81 | LMNA (0.57) | TLR2LMNAMAPTALDH1A1 | |
| SCHEMBL29131231 | 0.81 | LMNA (0.65) | LMNAMAPTALDH1A1 | |
| SCHEMBL10623472 | 0.80 | MAPT (0.59) | FAAHMAPTRXFP1ALDH1A1 | |
| SCHEMBL27572109 | 0.80 | MAPT (0.59) | FAAHMAPTRXFP1ALDH1A1 | |
| SCHEMBL18937135 | 0.79 | S1PR2 (0.48) | FAAHMGLLTLR2MAPTRXFP1 | |
| SCHEMBL5962564 | 0.79 | LMNA (0.56) | FAAHLMNAMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210023106-A1 | TOLL-LIKE RECEPTOR LIGANDS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210023106-A1 | TOLL-LIKE RECEPTOR LIGANDS | TLR1, TLR4, TLR6 | FAAH 2600/4885MGLL 1275/4885TLR2 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.